SPRINGFIELD, Ill. — The push continued Friday to make Illinois the second state to cap insulin costs.
Governor J.B. Pritzker and other state lawmakers joined forces to push for the passage of Senate Bill 667.
The bill would limit insulin to $100 per 30-day supply.
“This measure will cap costs at significantly below the $500-to-$900 payments many Illinoisans face every month,” said Pritzker.
The Illinois Department of Health has reported one Illinoisan out of every eight has diabetes.
Two of the better-known insulin brands, Sanofi’s Lantus and Novo Norsdisk’s Novolog, saw prices jump 600% between 2001 and 2018, according to IBM research.
“As prices have skyrocketed, more and more insulin users have been forced to substitute lower quality products or seek other options outside the country,” Pritzker added.
Numbers from AARP have shown 28% of Illinoisans with diabetes stopped using insulin because of costs.
SB 667 is scheduled to be reintroduced in the Illinois General Assembly’s October veto session.
